These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against β2 -glycoprotein i domain 1 and domain 4/5: ratio of anti-domain 1 to anti-domain 4/5 as a useful new biomarker for antiphospholipid syndrome. Andreoli L; Chighizola CB; Nalli C; Gerosa M; Borghi MO; Pregnolato F; Grossi C; Zanola A; Allegri F; Norman GL; Mahler M; Meroni PL; Tincani A Arthritis Rheumatol; 2015 May; 67(8):2196-204. PubMed ID: 25939498 [TBL] [Abstract][Full Text] [Related]
4. The emerging role of multiple antiphospholipid antibodies positivity in patients with antiphospholipid syndrome. Forastiero R; Martinuzzo M Expert Rev Clin Immunol; 2015; 11(11):1255-63. PubMed ID: 26295486 [TBL] [Abstract][Full Text] [Related]
5. Current management of antiphospholipid syndrome-related thrombosis. Puente D; Pombo G; Forastiero R Expert Rev Cardiovasc Ther; 2009 Dec; 7(12):1551-8. PubMed ID: 19954317 [TBL] [Abstract][Full Text] [Related]
6. What have we learned about antiphospholipid syndrome from patients and antiphospholipid carrier cohorts? Pengo V; Banzato A; Bison E; Bracco A; Denas G; Ruffatti A Semin Thromb Hemost; 2012 Jun; 38(4):322-7. PubMed ID: 22399307 [TBL] [Abstract][Full Text] [Related]
8. Role of tissue factor in thrombosis in antiphospholipid antibody syndrome. Boles J; Mackman N Lupus; 2010 Apr; 19(4):370-8. PubMed ID: 20353972 [TBL] [Abstract][Full Text] [Related]
9. Predominant prevalence of arterial thrombosis in Japanese patients with antiphospholipid syndrome. Fujieda Y; Atsumi T; Amengual O; Odani T; Otomo K; Kato M; Oku K; Kon Y; Horita T; Yasuda S; Koike T Lupus; 2012 Dec; 21(14):1506-14. PubMed ID: 22936124 [TBL] [Abstract][Full Text] [Related]
10. Intravenous immunoglobulins and antiphospholipid syndrome: How, when and why? A review of the literature. Tenti S; Cheleschi S; Guidelli GM; Galeazzi M; Fioravanti A Autoimmun Rev; 2016 Mar; 15(3):226-35. PubMed ID: 26656906 [TBL] [Abstract][Full Text] [Related]
11. Women's Issues in Antiphospholipid Syndrome. Papadakis E; Banti A; Kioumi A Isr Med Assoc J; 2016 Sep; 18(9):524-529. PubMed ID: 28471597 [TBL] [Abstract][Full Text] [Related]
15. From antibody to clinical phenotype, the black box of the antiphospholipid syndrome: pathogenic mechanisms of the antiphospholipid syndrome. Du VX; Kelchtermans H; de Groot PG; de Laat B Thromb Res; 2013 Sep; 132(3):319-26. PubMed ID: 23958468 [TBL] [Abstract][Full Text] [Related]
16. Antiphospholipid Syndrome and the Kidney. Sciascia S; Baldovino S; Schreiber K; Solfietti L; Roccatello D Semin Nephrol; 2015 Sep; 35(5):478-86. PubMed ID: 26573550 [TBL] [Abstract][Full Text] [Related]
18. Antiphospholipid syndrome: long-time research on pathogenic mechanisms has finally lead to new therapeutic strategies. Cervera R; Espinosa G Expert Opin Ther Targets; 2010 Dec; 14(12):1279-82. PubMed ID: 21058919 [TBL] [Abstract][Full Text] [Related]
19. Obstetric antiphospholipid syndrome: still a challenge. Levy RA; Jesús GR; Jesús NR Lupus; 2010 Apr; 19(4):457-9. PubMed ID: 20353988 [TBL] [Abstract][Full Text] [Related]
20. Interpretation and recommended testing for antiphospholipid antibodies. Galli M Semin Thromb Hemost; 2012 Jun; 38(4):348-52. PubMed ID: 22399305 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]